| John R Wittenborn, MD | |
|
215 Union Ave, Suite B, Bridgewater, NJ 08807-3063 | |
| (609) 261-5755 | |
| (609) 261-7199 |
| Full Name | John R Wittenborn |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 51 Years |
| Location | 215 Union Ave, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629145115 | NPI | - | NPPES |
| 669902 | Other | HIGHMARK | |
| 0231523000 | Other | AMERIHEALTH KEYSTONE PC | |
| 1161130 | Other | MECY HORIZON NJ HEALTH | |
| 2336458 | Other | NJ | AETNA |
| P2052026 | Other | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MA070083 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Entity Name | Headache & Neurology Center Of Nj, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871524066 PECOS PAC ID: 5698801850 Enrollment ID: O20100327000228 |
News Archive
New evidence that opioid agonists such as methadone and buprenorphine could substantially reduce drug-related deaths if more widely used in the community and prison, and for longer, has been published in Lancet Psychiatry.
The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.
The researchers showed that state-of-the-art techniques for rapidly analyzing changes in activity of all human genes will likely produce useful insights into the health of critically ill patients. The findings, which are available online and will be published in the March 29 issue of the Proceedings of the National Academy of Sciences, make it possible for physicians to begin answering important questions about critical care through genomic analysis.
Despite current beliefs, sugar intake is not directly associated with nonalcoholic fatty liver disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Rather, high-calorie diets promote the progression of this serious form of liver disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John R Wittenborn, MD Po Box 363, Bernardsville, NJ 07924-0363 Ph: (908) 696-8940 | John R Wittenborn, MD 215 Union Ave, Suite B, Bridgewater, NJ 08807-3063 Ph: (609) 261-5755 |
News Archive
New evidence that opioid agonists such as methadone and buprenorphine could substantially reduce drug-related deaths if more widely used in the community and prison, and for longer, has been published in Lancet Psychiatry.
The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.
The researchers showed that state-of-the-art techniques for rapidly analyzing changes in activity of all human genes will likely produce useful insights into the health of critically ill patients. The findings, which are available online and will be published in the March 29 issue of the Proceedings of the National Academy of Sciences, make it possible for physicians to begin answering important questions about critical care through genomic analysis.
Despite current beliefs, sugar intake is not directly associated with nonalcoholic fatty liver disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Rather, high-calorie diets promote the progression of this serious form of liver disease.
› Verified 2 days ago
Dr. Richard V Buonocore, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Us Highway 22, Ste 2, Bridgewater, NJ 08807 Phone: 732-302-1720 Fax: 732-302-1724 |